home / stock / chrs / chrs quote
Last: | $1.365 |
---|---|
Change Percent: | -1.8% |
Open: | $1.41 |
Close: | $1.39 |
High: | $1.41 |
Low: | $1.34 |
Volume: | 586,571 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.365 | $1.41 | $1.39 | $1.41 | $1.34 | 586,571 | 07-03-2024 |
$1.39 | $1.59 | $1.39 | $1.61 | $1.3709 | 3,982,214 | 07-02-2024 |
$1.61 | $1.73 | $1.61 | $1.76 | $1.6 | 1,109,417 | 07-01-2024 |
$1.73 | $1.71 | $1.73 | $1.79 | $1.685 | 4,584,413 | 06-28-2024 |
$1.7 | $1.7 | $1.7 | $1.76 | $1.67 | 1,680,985 | 06-27-2024 |
$1.66 | $1.57 | $1.66 | $1.67 | $1.55 | 1,634,847 | 06-26-2024 |
$1.58 | $1.62 | $1.58 | $1.65 | $1.56 | 1,440,922 | 06-25-2024 |
$1.63 | $1.69 | $1.63 | $1.7 | $1.58 | 3,326,424 | 06-24-2024 |
$1.67 | $1.63 | $1.67 | $1.72 | $1.62 | 1,301,809 | 06-21-2024 |
$1.62 | $1.61 | $1.62 | $1.66 | $1.58 | 854,934 | 06-20-2024 |
$1.62 | $1.63 | $1.62 | $1.7 | $1.61 | 694,558 | 06-19-2024 |
$1.62 | $1.63 | $1.62 | $1.7 | $1.61 | 694,558 | 06-18-2024 |
$1.64 | $1.69 | $1.64 | $1.69 | $1.6 | 1,856,103 | 06-17-2024 |
$1.69 | $1.72 | $1.69 | $1.75 | $1.66 | 1,865,532 | 06-14-2024 |
$1.78 | $1.83 | $1.78 | $1.83 | $1.74 | 712,115 | 06-13-2024 |
$1.82 | $1.8 | $1.82 | $1.865 | $1.77 | 1,686,351 | 06-12-2024 |
$1.73 | $1.74 | $1.73 | $1.77 | $1.7 | 1,020,106 | 06-11-2024 |
$1.74 | $1.69 | $1.74 | $1.75 | $1.61 | 1,298,360 | 06-10-2024 |
$1.69 | $1.72 | $1.69 | $1.75 | $1.68 | 905,027 | 06-07-2024 |
$1.74 | $1.8 | $1.74 | $1.8477 | $1.72 | 1,029,349 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Coherus BioSciences Inc. Company Name:
CHRS Stock Symbol:
NASDAQ Market:
Coherus BioSciences Inc. Website:
REDWOOD CITY, Calif., June 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc . (Coherus, Nasdaq: CHRS) today announced it agreed to divest YUSIMRY (adalimumab-aqvh) to Hong Kong King-Friend Industrial Co. Ltd. (HKF) for up-front all-cash consideration of $40 million. The closing of the tr...
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq: CHRS) today announced that Rita Karachun, CPA, CGMA, most recently Senior Vice President (SVP) and Global Controller for Merck & Co., Inc., (Merck) was appointed to its Board of ...
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:30 a.m. Eastern Daylight Time / 5:30 a.m. Pacific Dayl...